Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates and related services for the pharmaceutical industry.

Our core business sectors include custom synthesis and Generic API manufacturing.

The manufacturing site is located in Cameri, Italy. This 155,000 sq. meter, cutting-edge multipurpose plant, fully designed under cGMP compliance, has been successfully audited and approved by the main regulatory authorities including AIFA, FDA and PMDA.

To ensure our constant growth in an increasingly competitive market, Procos strives to pursue innovation, while keeping our core identity, by constantly investing in our company and in our people.

We are a locally rooted company yet part of an international network, with commercial offices in key strategic geographies.